| 注册
首页|期刊导航|中国医药科学|胸腺法新对多发性骨髓瘤患者淋巴细胞亚群的影响研究

胸腺法新对多发性骨髓瘤患者淋巴细胞亚群的影响研究

何晓娟 扶叶松 秦芳梅 吴春叶 朱飞跃

中国医药科学2025,Vol.15Issue(10):117-121,5.
中国医药科学2025,Vol.15Issue(10):117-121,5.DOI:10.20116/j.issn2095-0616.2025.10.26

胸腺法新对多发性骨髓瘤患者淋巴细胞亚群的影响研究

Research on the impact of thymalfasin on lymphocyte subsets in patients with multiple myeloma

何晓娟 1扶叶松 1秦芳梅 1吴春叶 1朱飞跃1

作者信息

  • 1. 湖南省娄底市中心医院血液内科,湖南 娄底 417000
  • 折叠

摘要

Abstract

Objective To investigate the impact of thymalfasin on the immune system by detecting T/B/NK lymphocyte counts in peripheral blood of patients with multiple myeloma(MM).Methods A total of 40 MM patients who received first-line chemotherapy with bortezomib in the Department of Hematology of Loudi Central Hospital from June 2021 to June 2023 were selected.They were divided into the experimental group(n=15)and the control group(n=25)based on whether they received subcutaneous injections of 1.6 mg thymalfasin simultaneously.The values of T/B/NK lymphocyte subsets before and 2 weeks after chemotherapy were collected,and the differences in cell expression levels in and between the two groups were compared.Results The changes of T/B/NK lymphocytes before and after treatment in the control group were not statistically significant(P>0.05).The use of thymofaxine in the experimental group before and after treatment increased the absolute count of CD3+T lymphocytes,mainly in the percentage and absolute count of CD3+CD8+T lymphocytes,and the difference was statistically significant(P<0.05).Before treatment,the absolute counts of CD3+,CD3+CD4+and CD3+CD8+T lymphocytes in the test group were significantly lower than those in the control group,and the difference was statistically significant(P<0.05),and the percentages and absolute counts of CD19+B lymphocytes were lower than those in the control group,and the difference was statistically significant(P<0.05).After treatment,the CD19+B lymphocytes and CD3-CD16+/56+NK cells absolute counts were lower than those of the control group,and the difference was statistically significant(P<0.05).Conclusion The combined use of thymalfasin during treatment in MM patients can increase T lymphocyte counts,improve cellular immunity,and enhance anti-infection ability,which has clinical application value.

关键词

多发性骨髓瘤/胸腺法新/淋巴细胞亚群/免疫调节

Key words

Multiple myeloma/Thymalfasin/Lymphocyte subsets/Immune regulation

分类

医药卫生

引用本文复制引用

何晓娟,扶叶松,秦芳梅,吴春叶,朱飞跃..胸腺法新对多发性骨髓瘤患者淋巴细胞亚群的影响研究[J].中国医药科学,2025,15(10):117-121,5.

基金项目

湖南省娄底市中心医院科研课题(Y2021-07). (Y2021-07)

中国医药科学

2095-0616

访问量0
|
下载量0
段落导航相关论文